BioAtla

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioAtla and other ETFs, options, and stocks.

About BCAB

BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021.

CEO

Jay M. Short

CEOJay M. Short

Employees

Employees76

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2007

Founded2007

Employees

Employees76

BCAB Key Statistics

Market cap

23.69M

Market cap23.69M

Price-Earnings ratio

-0.33

Price-Earnings ratio-0.33

Dividend yield

—

Dividend yield—

Average volume

498.51K

Average volume498.51K

High today

$0.4395

High today$0.4395

Low today

$0.3905

Low today$0.3905

Open price

$0.3985

Open price$0.3985

Volume

632.82K

Volume632.82K

52 Week high

$2.53

52 Week high$2.53

52 Week low

$0.24

52 Week low$0.24

People also own

Based on the portfolios of people who own BCAB. This list is generated using Robinhood data, and it’s not a recommendation.